Next 10 |
SOHM (OTC: SHMN) , a cutting-edge biopharmaceutical company focused on gene editing technologies, today announced its collaboration with Coastar Therapeutics, San Diego, California, a leading biotechnology company specializing in innovative drug delivery systems. The partnership aims to advance t...
CHINO HILLS, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today the collaboration with Coa...
Recently published data shows that rheumatoid arthritis patients have a heightened risk for developing depression. This study is the first to investigate the link between rheumatoid arthritis and the risk of developing depression. The researchers’ objective was to examine the effect of...
The FDA recently approved a plan that permits the state of Florida to import some drugs from Canada at lower prices than the medications that can be acquired in America. It is a well-known fact that the cost of drugs in the United States is high, with numerous studies finding that in comparison...
Prescription drugs have had a significant impact on human society. From treating temporary conditions and controlling chronic conditions, prescription drugs have been critical to preserving long-term health and quality of life for millions of people for well over a century. However, prescriptio...
A pilot study by researchers from the Medical University of South Carolina has revealed that an FDA-approved drug could help reduce the need for opioid administration after surgery. Scientists from the university’s Department of Anesthesia and Perioperative Medicine (MUSC) found that an ...
A newly found compound, CBD3063, has shown that it can be significantly effective at treating chronic pain in animal studies with barely any side effects. Scientists discovered the compound after screening a whopping 27 million potential drugs extensively. CBD3063 works by targeting the Cav2....
SOHM (OTC: SHMN) , a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, has filed a provisional patent application on its ABBIE Smart Gene-Editing platform. According to the announcement, the platform uses th...
2024-01-09 09:56:26 ET More on SOHM, Inc. Financial information for SOHM, Inc. For further details see: SOHM files provisional patent on its ABBIE ‘smart gene-editing’ platform
CHINO HILLS, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN) (the “Company”), a pharmaceutical, nutraceutical, cosmeceutical and biotech Company that manufactures and markets generic drugs covering numerous treatment categories, announces today t...
News, Short Squeeze, Breakout and More Instantly...
SOHM (OTC: SHMN) , a cutting-edge biopharmaceutical company focused on gene editing technologies, today announced its collaboration with Coastar Therapeutics, San Diego, California, a leading biotechnology company specializing in innovative drug delivery systems. The partnership aims to advance t...
CHINO HILLS, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today the collaboration with Coa...
Recently published data shows that rheumatoid arthritis patients have a heightened risk for developing depression. This study is the first to investigate the link between rheumatoid arthritis and the risk of developing depression. The researchers’ objective was to examine the effect of...